Rofecoxib Is a Potent, Metabolism-Dependent Inhibitor of CYP1A2: Implications for in Vitro Prediction of Drug Interactions (Q60449865)
Jump to navigation
Jump to search
scientific article published on 19 September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rofecoxib Is a Potent, Metabolism-Dependent Inhibitor of CYP1A2: Implications for in Vitro Prediction of Drug Interactions |
scientific article published on 19 September 2006 |
Statements
Rofecoxib is a potent, metabolism-dependent inhibitor of CYP1A2: implications for in vitro prediction of drug interactions (English)
Marjo J Karjalainen
19 September 2006